Sårbehandling

The new Mepilex® Transfer Ag – A Wound contact layer for undisturbed healing

Av: Mölnlycke Health Care, april 15 2014Postet i: Sårbehandling

 

The efficacy of wound contact layer dressings with antimicrobial properties in clinical wound care is well documented. But clinical considerations are only half the answer to reducing wound healing and treatment times. Another aspect is often overlooked, namely the patients’ experience and quality of life.

Research shows that pain, and even its anticipation, cause physiological stress reactions that have an adverse effect on healing 1-2. So it makes sense to approach wound care from a more patient-oriented perspective. As this should drive technological developments in wound care dressings, what can the public expect in the future?

To put it simply, a dressing cannot heal a wound – that’s the body’s job. Dressings can either disturb or support this healing process, and damage to the wound and skin will cause pain. Mölnlycke Health Care developed Mepilex Transfer Ag based on Safetac®technology to minimise damage and pain during dressing changes. In fact, all Safetac dressings are designed to take the unnecessary suffering out of wound care.

Mepilex Transfer Ag is a wound contact layer with the flexibility to create the optimal dressing combination for a specific wound type or exudate level. It combines a rapid antimicrobial effect (30 minutes) with a sustained continuation of up to fourteen days when required. This minimises the number of dressing changes that can disturb the wound.

The clinical benefits of Mepilex Transfer Ag - its rapid and sustained antimicrobial effect and its effective exudate management qualities - are now matched by a possibly more important focus on the patient’s wellbeing. This new holistic approach to wound care management has the potential, over the long term, to lower healthcare costs by promoting faster wound healing and treatment times.

Longer periods between less painful dressing changes, i.e. fewer occasions to disturb the healing process, clearly represent a step forward. That can only be good news for patients and professionals alike.

References:
1. Wiberg A.B. et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of the WUWHS, Toronto, Canada, 2008.
2. Upton D. et al. The Impact of Atraumatic Vs Conventional Dressings on Pain and Stress in Patients with Chronic Wounds. Submitted and approved for publication. Journal of Wound Care, 2012

Del dette

Mer fra den samme kategori

Spør ekspertene om bandasjens rolle...

Some of the world’s leading experts will take part in an outstanding symposium...

Mepilex Border Heel

  // The well established and highly successful product range of Mepilex® Border continues to...

EWMA trykksår symposiumrapport

The EWMA delegates who attended the Mölnlycke Health Care seminar on...

Mepilex Border Post-Op

  // The need for a reliable, surgically safe post-operative wound dressing for both clinical...

Bandasjens Konstruksjon: Bruk av flerlags...

During this year’s World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - et viktig element i sårbehandling:...

A recently published French study has confirmed the effectiveness of...

EWMA symposiumrapport om hvordan smerte...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

Kliniske tester viser at bandasjer er...

Hospital acquired pressure ulcers are a major challenge for medical practitioners....

Studie viser at Mepitel Film kan forebygge...

Radiation-induced skin reactions occur in 80-90% of breast cancer patients1 and...

Produktnyhet: Mepilex XT

Hittil har ikke skumbandasjer klart å håndtere tyktflytende sårvæske effektivt. Dette gjorde at...

Gode resultater med Mepilex XT

Ved Södersjukhuset i Sverige har de evaluert skumbandasjen Mepilex XT. ...

Exufiber ga Toivo tilbake hans normale...

Sår som heler langsomt krever ofte masse tid av helsepersonell, stort engasjement...